Skip to main content

3 Result(s)

within A. H. Heer-Sonderhoff Remove this filter

and

  1. No Access

    Chapter and Conference Paper

    Incidence and Severity of Amphotericin B-induced Acute Toxicity in Leukemic Patients After Treatment with Three Different Formulations (Amphotericin B, AmBisome and Amphotericin B/lntralipid) — A Pilot Study

    Intravenous amphotericin B (AmB) is the most potent drug for treatment of systemic fungal infections in leukemic patients. However, use of this drug is often limited by renal side effects and acute toxicity (f...

    M. Arning, K. O. Kliche, A. Wehmeier, A. H. Heer-Sonderhoff… in Acute Leukemias V (1996)

  2. No Access

    Article

    Neutrophilic dermal infiltrates in granulocytopenic patients with acute leukemia

    Acute febrile neutrophilic dermatosis (AFND, Sweet's syndrome) is clinically characterized by fever, neutrophilic leukocytosis, and tender dermal plaques. Histological examination typically reveals infiltratio...

    A. H. Heer-Sonderhoff, M. Arning, A. Wehmeier, T. Südhoff… in Annals of Hematology (1995)

  3. No Access

    Article

    Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia

    Pulmonary toxicity with acute dyspnea occurred during infusion of a liposomal amphotericin B preparation (AmBisome) in two adult leukemic patients. The preparation was administered as a one hour infusion at a ...

    M. Arning, A. H. Heer-Sonderhoff… in European Journal of Clinical Microbiology … (1995)